Tens of thousands of Americans experience sudden hearing loss each year. Now, a biotech company called Frequency Therapeutics is hoping to be the first to make it to market with a drug it claims will use patients’ own biology to restore what was lost. CBS News national correspondent Jericka Duncan reports.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
